metformin and ldn-212854

metformin has been researched along with ldn-212854 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, YG; Jiang, S; Lin, H; Luo, Z; Ueta, T; Vavvas, D; Wang, Y; Wen, R; Ying, Y	1

Other Studies

1 other study(ies) available for metformin and ldn-212854

Article	Year
Metformin inhibits ALK1-mediated angiogenesis via activation of AMPK. Oncotarget, 2017, May-16, Volume: 8, Issue:20 Topics: Activin Receptors, Type II; Adenylate Kinase; Angiogenesis Inhibitors; Animals; Choroidal Neovascularization; Enzyme Activation; Gene Expression Regulation, Neoplastic; Growth Differentiation Factor 2; Growth Differentiation Factors; Human Umbilical Vein Endothelial Cells; Humans; Metformin; Mice; Phosphorylation; Pyrazoles; Pyrimidines; Quinolines; Smad1 Protein; Smad5 Protein; Xenograft Model Antitumor Assays	2017

Article

Year

Metformin inhibits ALK1-mediated angiogenesis via activation of AMPK.

Oncotarget, 2017, May-16, Volume: 8, Issue:20

Topics: Activin Receptors, Type II; Adenylate Kinase; Angiogenesis Inhibitors; Animals; Choroidal Neovascularization; Enzyme Activation; Gene Expression Regulation, Neoplastic; Growth Differentiation Factor 2; Growth Differentiation Factors; Human Umbilical Vein Endothelial Cells; Humans; Metformin; Mice; Phosphorylation; Pyrazoles; Pyrimidines; Quinolines; Smad1 Protein; Smad5 Protein; Xenograft Model Antitumor Assays

2017